Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 61

Related Articles by Review for PubMed (Select 19185342)

1.

Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis.

Cipriani A, Furukawa TA, Salanti G, Geddes JR, Higgins JP, Churchill R, Watanabe N, Nakagawa A, Omori IM, McGuire H, Tansella M, Barbui C.

Lancet. 2009 Feb 28;373(9665):746-58. doi: 10.1016/S0140-6736(09)60046-5. Review.

PMID:
19185342
2.

[Clinical efficacy and achievement of a complete remission in depression: increasing interest in treatment with escitalopram].

Favré P.

Encephale. 2012 Feb;38(1):86-96. doi: 10.1016/j.encep.2011.11.003. Epub 2011 Dec 10. Review. French.

PMID:
22381728
3.

Citalopram versus other anti-depressive agents for depression.

Cipriani A, Purgato M, Furukawa TA, Trespidi C, Imperadore G, Signoretti A, Churchill R, Watanabe N, Barbui C.

Cochrane Database Syst Rev. 2012 Jul 11;7:CD006534. doi: 10.1002/14651858.CD006534.pub2. Review.

4.

Duloxetine versus other anti-depressive agents for depression.

Cipriani A, Koesters M, Furukawa TA, Nosè M, Purgato M, Omori IM, Trespidi C, Barbui C.

Cochrane Database Syst Rev. 2012 Oct 17;10:CD006533. doi: 10.1002/14651858.CD006533.pub2. Review.

5.

Escitalopram versus other antidepressive agents for depression.

Cipriani A, Santilli C, Furukawa TA, Signoretti A, Nakagawa A, McGuire H, Churchill R, Barbui C.

Cochrane Database Syst Rev. 2009 Apr 15;(2):CD006532. doi: 10.1002/14651858.CD006532.pub2. Review.

6.

Agomelatine versus other antidepressive agents for major depression.

Guaiana G, Gupta S, Chiodo D, Davies SJ, Haederle K, Koesters M.

Cochrane Database Syst Rev. 2013 Dec 17;12:CD008851. doi: 10.1002/14651858.CD008851.pub2. Review.

PMID:
24343836
7.

Fluoxetine versus other types of pharmacotherapy for depression.

Magni LR, Purgato M, Gastaldon C, Papola D, Furukawa TA, Cipriani A, Barbui C.

Cochrane Database Syst Rev. 2013 Jul 17;7:CD004185. Review.

PMID:
24353997
8.

[Efficacy of escitalopram and severity of depression: new data].

Spadone C.

Encephale. 2009 Dec;35(6):577-85. doi: 10.1016/j.encep.2009.10.004. Epub . Review. French.

PMID:
20004289
9.

Sertraline versus other antidepressive agents for depression.

Cipriani A, La Ferla T, Furukawa TA, Signoretti A, Nakagawa A, Churchill R, McGuire H, Barbui C.

Cochrane Database Syst Rev. 2009 Apr 15;(2):CD006117. doi: 10.1002/14651858.CD006117.pub2. Review. Update in: Cochrane Database Syst Rev. 2010;(1):CD006117.

PMID:
19370626
10.

Comparative benefits and harms of second-generation antidepressants: background paper for the American College of Physicians.

Gartlehner G, Gaynes BN, Hansen RA, Thieda P, DeVeaugh-Geiss A, Krebs EE, Moore CG, Morgan L, Lohr KN.

Ann Intern Med. 2008 Nov 18;149(10):734-50. Review.

PMID:
19017592
11.

Fluoxetine versus other types of pharmacotherapy for depression.

Cipriani A, Brambilla P, Furukawa T, Geddes J, Gregis M, Hotopf M, Malvini L, Barbui C.

Cochrane Database Syst Rev. 2005 Oct 19;(4):CD004185. Review. Update in: Cochrane Database Syst Rev. 2013;7:CD004185.

12.

Sertraline versus other antidepressive agents for depression.

Cipriani A, La Ferla T, Furukawa TA, Signoretti A, Nakagawa A, Churchill R, McGuire H, Barbui C.

Cochrane Database Syst Rev. 2010 Apr 14;(4):CD006117. doi: 10.1002/14651858.CD006117.pub4. Review.

13.

Sertraline versus other antidepressive agents for depression.

Cipriani A, La Ferla T, Furukawa TA, Signoretti A, Nakagawa A, Churchill R, McGuire H, Barbui C.

Cochrane Database Syst Rev. 2010 Jan 20;(1):CD006117. doi: http://dx.doi.org/10.1002/14651858.CD006117. Review. Update in: Cochrane Database Syst Rev. 2010;(4):CD006117.

PMID:
20091586
14.

Efficacy and safety of second-generation antidepressants in the treatment of major depressive disorder.

Hansen RA, Gartlehner G, Lohr KN, Gaynes BN, Carey TS.

Ann Intern Med. 2005 Sep 20;143(6):415-26. Review.

PMID:
16172440
15.

Milnacipran versus other antidepressive agents for depression.

Nakagawa A, Watanabe N, Omori IM, Barbui C, Cipriani A, McGuire H, Churchill R, Furukawa TA.

Cochrane Database Syst Rev. 2009 Jul 8;(3):CD006529. doi: 10.1002/14651858.CD006529.pub2. Review.

16.

Pharmacological and clinical profile of newer antidepressants: implications for the treatment of elderly patients.

Dolder C, Nelson M, Stump A.

Drugs Aging. 2010 Aug 1;27(8):625-40. doi: 10.2165/11537140-000000000-00000. Review.

PMID:
20658791
17.

Efficacy and tolerability of milnacipran in the treatment of major depression in comparison with other antidepressants : a systematic review and meta-analysis.

Nakagawa A, Watanabe N, Omori IM, Barbui C, Cipriani A, McGuire H, Churchill R, Furukawa TA; Multiple Meta-Analyses of New-Generation Antidepressants (MANGA) Study Group.

CNS Drugs. 2008;22(7):587-602. Review.

PMID:
18547127
18.

Clinically relevant pharmacokinetic drug interactions with second-generation antidepressants: an update.

Spina E, Santoro V, D'Arrigo C.

Clin Ther. 2008 Jul;30(7):1206-27. Review.

PMID:
18691982
19.
20.

[Use of antidepressant drugs in schizophrenic patients with depression].

Micallef J, Fakra E, Blin O.

Encephale. 2006 Mar-Apr;32(2 Pt 1):263-9. Review. French.

PMID:
16910628
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk